Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 10 studies | 21% ± 6% | |
smooth muscle cell | 9 studies | 19% ± 3% | |
glutamatergic neuron | 6 studies | 31% ± 20% | |
classical monocyte | 5 studies | 23% ± 6% | |
astrocyte | 5 studies | 28% ± 7% | |
endothelial cell | 4 studies | 26% ± 10% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 5% | |
interneuron | 4 studies | 28% ± 20% | |
fibroblast | 3 studies | 29% ± 11% | |
GABAergic neuron | 3 studies | 45% ± 18% | |
neuron | 3 studies | 27% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 24% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 7172.43 | 2638 / 2642 | 100% | 73.12 | 704 / 705 |
ovary | 100% | 5568.03 | 180 / 180 | 99% | 47.30 | 424 / 430 |
thymus | 100% | 3831.47 | 652 / 653 | 97% | 26.15 | 584 / 605 |
adrenal gland | 100% | 5284.43 | 258 / 258 | 95% | 25.40 | 218 / 230 |
prostate | 100% | 5332.95 | 244 / 245 | 90% | 11.98 | 452 / 502 |
breast | 100% | 3304.79 | 459 / 459 | 85% | 14.07 | 949 / 1118 |
skin | 87% | 1485.37 | 1570 / 1809 | 91% | 15.76 | 429 / 472 |
lung | 99% | 2948.70 | 573 / 578 | 78% | 11.15 | 903 / 1155 |
kidney | 99% | 2646.88 | 88 / 89 | 77% | 11.95 | 690 / 901 |
pancreas | 78% | 1399.08 | 257 / 328 | 92% | 15.29 | 163 / 178 |
bladder | 100% | 3203.86 | 21 / 21 | 55% | 6.47 | 276 / 504 |
uterus | 100% | 3736.43 | 170 / 170 | 53% | 11.41 | 242 / 459 |
stomach | 97% | 2182.53 | 350 / 359 | 33% | 3.23 | 94 / 286 |
esophagus | 82% | 2356.92 | 1188 / 1445 | 41% | 4.33 | 75 / 183 |
intestine | 86% | 2485.08 | 827 / 966 | 27% | 2.39 | 141 / 527 |
blood vessel | 100% | 5774.83 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 6547.56 | 803 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 2774.88 | 1201 / 1204 | 0% | 0 | 0 / 0 |
spleen | 97% | 1876.30 | 234 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 5595.29 | 834 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 14.62 | 77 / 80 |
peripheral blood | 69% | 2327.77 | 640 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 34% | 2.05 | 10 / 29 |
liver | 6% | 61.05 | 13 / 226 | 26% | 3.95 | 107 / 406 |
tonsil | 0% | 0 | 0 / 0 | 16% | 1.25 | 7 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
GO_0030071 | Biological process | regulation of mitotic metaphase/anaphase transition |
GO_0010971 | Biological process | positive regulation of G2/M transition of mitotic cell cycle |
GO_0045582 | Biological process | positive regulation of T cell differentiation |
GO_0042692 | Biological process | muscle cell differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_0045663 | Biological process | positive regulation of myoblast differentiation |
GO_0051152 | Biological process | positive regulation of smooth muscle cell differentiation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0070316 | Biological process | regulation of G0 to G1 transition |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0003219 | Biological process | cardiac right ventricle formation |
GO_2000819 | Biological process | regulation of nucleotide-excision repair |
GO_0006337 | Biological process | nucleosome disassembly |
GO_0003139 | Biological process | secondary heart field specification |
GO_2000781 | Biological process | positive regulation of double-strand break repair |
GO_0007399 | Biological process | nervous system development |
GO_0003407 | Biological process | neural retina development |
GO_0071565 | Cellular component | nBAF complex |
GO_0071564 | Cellular component | npBAF complex |
GO_0016514 | Cellular component | SWI/SNF complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0035060 | Cellular component | brahma complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0001221 | Molecular function | transcription coregulator binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0003713 | Molecular function | transcription coactivator activity |
Gene name | SMARCD3 |
Protein name | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 (60 kDa BRG-1/Brm-associated factor subunit C) (BRG1-associated factor 60C) (BAF60C) SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
Synonyms | BAF60C tcag7.774 |
Description | FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Stimulates nuclear receptor mediated transcription. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). . |
Accessions | ENST00000356800.6 [Q6STE5-2] ENST00000392811.6 [Q6STE5-2] F8WBJ3 ENST00000485592.5 ENST00000491651.1 Q6STE5 A0A090N8Z9 H7C4E9 ENST00000469154.5 C9JYI7 ENST00000262188.13 [Q6STE5-1] |